Gilead Sciences, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3755581036
USD
122.62
-1.29 (-1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
28,727.00
27,058.00
27,085.00
27,372.00
24,642.00
22,322.00
22,214.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
28,727.00
27,058.00
27,085.00
27,372.00
24,642.00
22,322.00
22,214.00
Raw Material Cost
6,251.00
6,019.00
5,657.00
6,601.00
4,509.00
4,675.00
4,853.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
977.00
944.00
935.00
1,001.00
984.00
995.00
1,077.00
Selling and Distribution Expenses
6,000.00
5,537.00
5,673.00
5,207.00
4,832.00
4,381.00
4,056.00
Other Expenses
483.90
481.40
406.30
436.20
387.30
731.10
312.10
Total Expenditure (Excl Depreciation)
18,067.00
17,314.00
16,328.00
17,171.00
14,198.00
17,362.00
13,107.00
Operating Profit (PBDIT) excl Other Income
10660
9744
10757
10201
10444
4960
9107
Other Income
271.00
366.00
205.00
600.00
-4,850.00
773.00
476.00
Operating Profit (PBDIT)
13,698.00
12,803.00
13,065.00
12,851.00
7,074.00
7,137.00
11,012.00
Interest
977.00
944.00
935.00
1,001.00
984.00
995.00
1,077.00
Exceptional Items
-9,264.00
-2,307.00
-4,213.00
-1,522.00
-2,941.00
422.00
-707.00
Gross Profit (PBDT)
22,476.00
21,039.00
21,428.00
20,771.00
20,133.00
17,647.00
17,361.00
Depreciation
2,767.00
2,693.00
2,103.00
2,050.00
1,480.00
1,404.00
1,429.00
Profit Before Tax
690.00
6,859.00
5,814.00
8,278.00
1,669.00
5,160.00
7,799.00
Tax
210.00
1,246.00
1,248.00
2,077.00
1,580.00
-204.00
2,339.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
480.00
5,665.00
4,592.00
6,225.00
123.00
5,386.00
5,455.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
480.00
5,665.00
4,592.00
6,225.00
123.00
5,386.00
5,455.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-52.00
-26.00
-24.00
-34.00
-22.00
5.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
480.00
5,613.00
4,566.00
6,201.00
89.00
5,364.00
5,460.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
19,330.00
22,833.00
21,240.00
21,069.00
18,202.00
22,525.00
21,387.00
Earnings per share (EPS)
0.38
4.5
3.64
4.93
0.1
4.22
4.17
Diluted Earnings per share
0.38
4.5
3.64
4.93
0.1
4.22
4.17
Operating Profit Margin (Excl OI)
37.11%
36.01%
39.72%
37.27%
42.38%
22.22%
41.0%
Gross Profit Margin
12.03%
35.3%
29.23%
37.73%
12.78%
29.41%
41.54%
PAT Margin
1.67%
20.94%
16.95%
22.74%
0.5%
24.13%
24.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.17% vs -0.10% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -91.45% vs 22.93% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 7.96% vs -3.29% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 3.50% vs 0.96% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Gilead Sciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
28,727.00
33,232.00
-4,505.00
-13.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
28,727.00
33,232.00
-4,505.00
-13.56%
Raw Material Cost
6,251.00
11,899.00
-5,648.00
-47.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
977.00
3,224.00
-2,247.00
-69.70%
Selling and Distribution Expenses
6,000.00
7,096.00
-1,096.00
-15.45%
Other Expenses
483.90
245.20
238.70
97.35%
Total Expenditure (Excl Depreciation)
18,067.00
24,671.00
-6,604.00
-26.77%
Operating Profit (PBDIT) excl Other Income
10,660.00
8,561.00
2,099.00
24.52%
Other Income
271.00
173.00
98.00
56.65%
Operating Profit (PBDIT)
13,698.00
14,078.00
-380.00
-2.70%
Interest
977.00
3,224.00
-2,247.00
-69.70%
Exceptional Items
-9,264.00
-653.00
-8,611.00
-1,318.68%
Gross Profit (PBDT)
22,476.00
21,333.00
1,143.00
5.36%
Depreciation
2,767.00
5,592.00
-2,825.00
-50.52%
Profit Before Tax
690.00
4,609.00
-3,919.00
-85.03%
Tax
210.00
519.00
-309.00
-59.54%
Provisions and contingencies
0
0
0.00
Profit After Tax
480.00
4,090.00
-3,610.00
-88.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
480.00
4,090.00
-3,610.00
-88.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
480.00
4,090.00
-3,610.00
-88.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
19,330.00
5,877.00
13,453.00
228.91%
Earnings per share (EPS)
0.38
7.56
-7.18
-94.97%
Diluted Earnings per share
0.38
7.56
-7.18
-94.97%
Operating Profit Margin (Excl OI)
37.11%
25.02%
0.00
12.09%
Gross Profit Margin
12.03%
30.70%
0.00
-18.67%
PAT Margin
1.67%
12.31%
0.00
-10.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,872.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.17% vs -0.10% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 48.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -91.45% vs 22.93% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,342.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.96% vs -3.29% in Dec 2023

Annual - Interest
Interest 97.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.50% vs 0.96% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.11%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023